Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
Cook LB, O'Dell G, Vourvou E, Palanicawandar R, Marks S, Milojkovic D, Apperley JF, Loaiza S, Claudiani S, Bua M, Hockings C, Macdonald D, Chaidos A, Pavlu J, Cooper N, Fidler S, Randell P, Innes AJ.
Cook LB, et al. Among authors: pavlu j.
Nat Commun. 2022 Nov 14;13(1):6922. doi: 10.1038/s41467-022-34657-z.
Nat Commun. 2022.
PMID: 36376307
Free PMC article.